Companies / Canada
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Merck & Co Gains Canadian Approval For Rotateq
August 2006 | Product LaunchSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Health Canada has approved domestic company Merck Frosst's RotaTeq, making it the first vaccine available in Canada for the prevention of rotavirus gastroenteritis in infants, ahead of UK firm GlaxoSmithKline's competing vaccine, Rotarix, which was developed